Concepedia

Zheyong Liang

ZL

8

Publications

433

Citations

8

H-Index

2012

Active since

Affiliations

First Affiliated Hospital of Xi'an Jiaotong University(Current)

Cancer Genetics (United States)

Roswell Park Comprehensive Cancer Center

Boston University

Xi'an Jiaotong University

Zheyong Liang is an author at First Affiliated Hospital of Xi'an Jiaotong University specializing in medicine, tumor biology, and cell biology.

ORCID

Top concepts

Publications per year

2012–2017

8

Publications

8

MCM7 promotes cancer progression through cyclin D1-dependent signaling and serves as a prognostic marker for patients with hepatocellular carcinoma

Kai Qu, Zhixin Wang, Haining Fan et al. · Cell Death and Disease · 2017 · 109 citations · Full text

Simvastatin suppresses the DNA replication licensing factor MCM7 and inhibits the growth of tamoxifen-resistant breast cancer cells

Zheyong Liang, Wenjie Li, Jie Liu et al. · Scientific Reports · 2017 · 65 citations · Full text

Loss of DLG5 promotes breast cancer malignancy by inhibiting the Hippo signaling pathway

Jie Liu, Juan Li, Pingping Li et al. · Scientific Reports · 2017 · 64 citations · Full text

CRB3 regulates contact inhibition by activating the Hippo pathway in mammary epithelial cells

Xiaona Mao, Pingping Li, Yaochun Wang et al. · Cell Death and Disease · 2017 · 47 citations · Full text

, , +14

RETRACTED ARTICLE: Simvastatin and Atorvastatin inhibit DNA replication licensing factor MCM7 and effectively suppress RB-deficient tumors growth

Juan Li, Jie Liu, Zheyong Liang et al. · Cell Death and Disease · 2017 · 45 citations · Full text

Rows per page

1–5 of 8